weight loss plateau glp 1 Struggling with GLP-1 Loss? Here's What to Do Next Break Your GLP-1 Weight Loss
Description
Enhancing Affordability: With branded Ozempic typically costing over C$200/month, the introduction of multiple generic options could lead to more competitive pricing, potentially making obesity care more accessible for many Canadians
Novo Nordisk, EVOKE and EVOKE+ phase 3 trial topline results, Alzheimers Association statement, 2025
Mixing alcohol with GLP-1 medications like semaglutide requires careful consideration
Rapid loss of muscle mass
This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)
Source: Novo Nordisk - PR Newswire
